The Editor, Eric Rowinsky, and the Associate Editors would like to acknowledge the valuable contributions of the reviewers to the journal. We fully understand the burden and effort that are involved in the reviews and are very grateful for your support. We rely on your expertise to maintain the standards of excellent science for the journal, Investigational New Drugs.
Yasushi Adachi
Barbara Altieri
Kyaw Aung
Koichi Azuma
Jan Beumer
Giampaolo Bianchini
Javier Blanco
P. Callery
E. Calvino
Ralph Chebib
Vincent Chung
Kristen Ciombor
Wilson Clements
Romain Coriat
Denise de Oliveira Silva
Roberto Dominguez
R. Donald Harvey
Afshin Dowlati
Hélène Elleaume
Bratko Filipič
Mashide Fukudo
Ariela Fundia
Jessica Geiger
Marwan Ghosn
Beppe Giaccone
Francis Giles
Lia Gore
James Groome
Eiki Ichihara
Koji Izutsu
Matthew J. Ellis
Charles J. Rosser
Angeles Juarranz
Masahi Kanai
Katie Kelley
Christian Klein
Vincent Launay-Vacher
Christophe LeTourneau
Chia-Chi (Josh) Lin
M. Lolkema
Harry Lybeck
Flamini Marina Ines
Hironobu Minami
Olivier Mir
Manoj Mishra
Monica Mita
Susan Mooberry
Aung Naing
David Naor
Andrea Necchi
Naoyuki Nogami
Mukesh Nyati
Ingo Ott
Neven Patrick
Philip Philip
Wenbin Qian
Marta Romero
Benoit Rousseau
Yuval Shaked
Guru Sonpavde
Toru Sugiyama
Young Suk Park
Matthew Sydes
Stefan Symeonides
Robak T.
Andreas Tzakos
Brian Van Tine
Nevena Veljkovic
Singurd Vitols
Dan von Hoff
J. Watanabe
Glen Weiss
Robert Weslowski
Robert Wesolowski
Christian Woloch
Nigel Wynn
K. Yamada
Gokhan Zengin
Xiaofeng Zhu
Rights and permissions
About this article
Cite this article
Acknowledgement of Reviewers 2016. Invest New Drugs 35, 125 (2017). https://doi.org/10.1007/s10637-017-0426-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-017-0426-3